The information below has been supplied by dairy marketers and other industry organizations. It has not been edited, verified or endorsed by Hoard’s Dairyman.
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced its SenseHub® Dairy technology has reached a major new milestone with more than 2 million dairy cows monitored in the United States.
This achievement reinforces SenseHub Dairy’s leadership as adoption of the technology continues to accelerate among dairy producers. In 2021, Merck Animal Health celebrated 1 million cows monitored — 13 years after entering the North American market. It took the company only four more years to reach this 2 millionth cow milestone. Today, more U.S. dairy producers rely on SenseHub Dairy than any other monitoring technology to gather data and insights to enhance the productivity of their herds.
“Backed by our commitment to innovation and customer success, SenseHub Dairy continues to set the gold standard for technology solutions for the dairy industry,” says Paul Koffman, executive director, technology solutions, Merck Animal Health. “Dairy producers rely on SenseHub technology to optimize labor and make data-driven management decisions to improve farm performance and profitability, whether it’s in the breeding pen, milking parlor, calf hutch or another area of the farm.”
The evolution of SenseHub Dairy dates to 2013, when SCR Dairy expanded its monitoring capability to measure multiple cow behaviors and deliver complex herd analyses that allowed producers to focus on the cows that may need attention, leaving the rest of the herd alone. Allflex acquired SCR Dairy in 2014, further expanding capabilities and distribution. Merck Animal Health purchased the parent company of Allflex in 2019, bringing livestock monitoring, identification and biopharma together in the industry’s first full solution source.
“Reaching the 2 millionth cow milestone is possible due to significant investments by Merck Animal Health to provide dairy producers an unparalleled portfolio of products, tailored service and support, and insights-driven solutions to improve cow care and operational efficiency,” Koffman adds.
The SenseHub technology platform developed by Merck Animal Health has consistently pioneered advancements in dairy monitoring technology, including:
- The dairy industry’s first rumination monitoring technology, providing producers improved reproductive and health management.
- The first LED light-enabled monitoring ear tag to allow producers to quickly identify animals that may need attention, at a glance.
- The introduction of SenseHub Dairy Youngstock, the industry’s first monitoring technology for calves from birth to one year of age.
Beyond dairy, Merck Animal Health continues to expand its leadership in U.S. cattle monitoring with SenseHub Cow Calf for beef breeding herds and SenseHub Feedlot for beef backgrounding, stocker, and feedlot operations.
About Merck Animal Health
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than a century, we’ve been at the forefront of research, bringing forward medicines, vaccines and innovative health solutions for the world’s most challenging diseases. Merck Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA, is the global animal health business of Merck. Through its commitment to The Science of Healthier Animals®, Merck Animal Health offers veterinarians, farmers, producers, pet owners and governments one of the widest ranges of veterinary pharmaceuticals, vaccines and health management solutions and services as well as an extensive suite of connected technology that includes identification, traceability and monitoring products. Merck Animal Health is dedicated to preserving and improving the health, well-being and performance of animals and the people who care for them. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. Merck Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.merck-animal-health.com and connect with us on LinkedIn, Facebook, X (formerly Twitter) and Instagram.
Forward-Looking Statement of Merck & Co., Inc., Rahway, N.J., USA
This news release of Merck & Co., Inc., Rahway, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline candidates that the candidates will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s Annual Report on Form 10-K for the year ended December 31, 2024 and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).
